XML 37 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Note 6 - Income Taxes
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

NOTE 6INCOME TAXES:

 

The components of income tax expense (benefit) were as follows:

 

  

For The Years Ended December 31,

 
  

2020

  

2019

  

2018

 

Current:

            

U.S. Federal

 $(5,933) $15,905  $20,634 

U.S. State

  (2,294)  4,717   3,240 

Non-U.S.

  514   1,336   1,436 
   (7,713)  21,958   25,310 

Deferred:

            

U.S. Federal

  10,936   (9,386)  (7,509)

U.S. State

  749   (8,033)  (8,973)
   11,685   (17,419)  (16,482)
             

Total Income Tax Expense

 $3,972  $4,539  $8,828 

 

A reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 21% to (loss) income from operations before income tax is:

 

  

For the Years Ended December 31,

 
  

2020

  

2019

  

2018

 
  

Amount

  

Percent

  

Amount

  

Percent

  

Amount

  

Percent

 

Statutory U.S. federal income tax rate

 $(1,941)  21.0% $20,600   21.0% $39,399   21.0%

State income taxes, net of federal tax benefit

  (1,109)  12.0   3,125   3.2   3,240   1.7 

Effect of foreign income taxes

  406   (4.4)  1,336   1.4   28    

Excess tax depletion

        (13,141)  (13.4)  (20,873)  (11.1)

Effect of change in U.S. tax law

              2,777   1.5 

Compensation

  1,310   (14.2)  1,799   1.8   935   0.5 

Valuation allowance

  1,479   (16.0)  1,400   1.4   (1,379)  (0.7)

Tax credits

  1,150   (12.4)  (2,536)  (2.6)  (980)  (0.5)

Non-controlling interest

  726   (7.9)  (3,687)  (3.8)  (5,420)  (2.9)

State rate change and prior period adjustments

  1,797   (19.4)  (4,565)  (4.6)  (9,448)  (5.0)

Other

  154   (1.6)  208   0.2   549   0.3 

Income Tax Expense / Effective Rate

 $3,972   (42.9)% $4,539   4.6% $8,828   4.8%

 

Significant components of deferred tax assets and liabilities were as follows:

 

  

December 31,

 
  

2020

  

2019

 

Deferred Tax Asset:

        

Postretirement benefits other than pensions

 $101,673  $110,504 

Pneumoconiosis benefits

  60,284   52,521 

Asset retirement obligations

  56,779   60,260 

Workers' compensation

  17,493   16,750 

Mine subsidence

  17,271   17,110 

Operating lease liability

  11,377   14,757 

Salary retirement

  9,446   14,761 

State bonus, net of Federal

  6,918   7,042 
Net operating loss  6,134    
Compensation  5,158   3,841 

Long-term disability

  2,757   3,031 

Financing

  2,077   16,806 

Foreign tax credits

     1,400 

Other

  4,175   2,456 

Total Deferred Tax Asset

  301,542   321,239 

Valuation Allowance

  (2,879)  (1,400)

Net Deferred Tax Asset

  298,663   319,839 
         

Deferred Tax Liability:

        

Property, plant and equipment

  (172,026)  (173,849)

Equity Partnerships

  (35,570)  (17,028)

Right of use assets

  (11,338)  (14,757)

Advance mining royalties

  (10,908)  (10,700)

Total Deferred Tax Liability

  (229,842)  (216,334)
         

Net Deferred Tax Asset

 $68,821  $103,505 

 

Certain provisions of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), which was signed into law by the President of the United States in March 2020, impact the Company and are therefore contemplated in the 2020 income tax provision computations. The CARES Act contained modifications on the limitation of business interest such that the Company anticipates full utilization of all interest expense for federal income tax purposes.

 

At  December 31, 2020, the Company has net operating loss carryforwards of approximately $15,135 and $40,032 for federal and state income tax purposes, respectively, which will be available to offset future taxable income. Approximately $25,180 will not expire and the remaining amount, if unused, will expire between 2030 and 2040.

 

As required by U.S. GAAP, a valuation allowance is required when it is more likely than not that all or a portion of a deferred tax asset will not be realized. Management must review all available evidence, both positive and negative, in determining the need for a valuation allowance. After considering all available evidence, management has determined that a valuation allowance in the amount of $2,879 is appropriate to establish for certain state tax attributes not anticipated to be utilized before expiration.

 

The Company utilizes the “more likely than not” standard in recognizing a tax benefit in its financial statements. For the years ended  December 31, 2020 and 2019, the Company did not have any unrecognized tax benefits. 

 

The Company is subject to taxation in the United States and its various states, as well as Canada and its various provinces. Under the provisions of the Tax Matters Agreement between the Company and its former parent, certain subsidiaries of the Company are subject to examination for tax years beginning December 31, 2016 through November 28, 2017. Furthermore, the Company is subject to examination for the period November 28, 2017 through December 31, 2020 for federal and state returns.